FFR vs Angiography Guided CABG

In the daily practice and in randomized studies such as Syntax or Freedom, most cardiovascular surgeons across the world use angiography guided CABG to teat 50% coronary stenosis. Many of these lesions might not be functionally significant.

El FFR ahorra síntomas a los pacientes y costos a los financiadores de saludThere is abundant evidence in favor of fractional flow reserve (FFR) guided PCI, but FFR guided CABG is something altogether different. There is little evidence to support the latter, but even if there were enough data, convincing surgeons to make this paradigm shift would take time.

 

So far, FFR guided CABG has been associated to lower number of graft anastomoses, lower rate of on-pump surgery, and higher graft patency rate compared to angiography guided CABG.


Read also: First Results for Ticagrelor in Elective Coronary Angioplasty.


This recent retrospective study published in Circ. Cardiovasc. Interv. included 627 consecutive patients undergoing CABG between 2006 and 2010. In 198 patients at least one stenosis was grafted according to FFR, whereas in the remaining 429, all lesions were grafted based on angiography. In the FFR guided group, patients were younger and less often had diabetes, compared against the angiography group, which is why they used propensity score.

 

At 6-year follow-up, global mortality rate, or acute myocardial infarction rate, was significantly lower in the FFR guided group (n=31 (16%) vs n=49 (25%); HR 0.59; p=0.02) compared against the angiography guided group.


Read also: Great Dispersion in the Prognosis of Patients with Angina and No Coronary Lesions.


A few days ago, we commented on the study published in J Am Coll Cardiol Intv which sets only half of interventional cardiologists systematically use FFR in the daily practice; the other half, despite supporting evidence and despite the tools available, simply consider conventional angiography to be enough. Surgeons seem even harder to convince.

 

Conclusion

FFR guided myocardial revascularization surgery is associated to a significant reduction of death or acute myocardial infarction at 6 years, compared against angiography guided CABG.

 

Original title: Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery.

Reference: Stephane Fournier et al. Circ Cardiovasc Interv. 2018 Jun;11(6):e006368.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...